We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Potential Blood Test for Heart Disease Discovered

By LabMedica International staff writers
Posted on 23 Jul 2013
Print article
Image: Histology of an atherosclerotic plaque (Photo courtesy of Boston University).
Image: Histology of an atherosclerotic plaque (Photo courtesy of Boston University).
A simple blood test may reveal that patients with heart ailments are actually suffering from the more dangerous coronary artery disease.

Coronary artery disease results when plaque grows in the arteries until blood flow to the heart is constricted and if enough plaque builds up, a piece could break off and block blood flow to the heart, which results in a heart attack or stroke.

An interdisciplinary team at the University of Nebraska (Omaha, NE, USA) while looking for clues to help understand inflammatory conditions such as arthritis and alcoholic liver disease, focused on a molecule that is a strong indicator of inflammation. The molecule, known as malondialdehyde–acetaldehyde or MAA also appeared to indicate the presence of coronary artery disease.

Over the course of two pilot studies, the team tested hundreds of volunteer patients' blood, and found a remarkable correlation. Any test developed from the discovery would be cheap and easy to implement with any clinical laboratory facility's existing equipment. It would be a simple blood test, not unlike tests that measure blood-sugar levels for diabetics.

The initial results have gained attention elsewhere as the team and University of Nebraska Medical Center’s technology transfer office, UNeMed Corporation (Omaha, NE, USA) are currently in preliminary discussions with several companies on how to translate the results into products that can better factor in a patient’s risk of heart attack. The scientists hope the test could be used to definitively inform younger patients in their forties, thirties, or even their twenties, whether or not they will develop potentially fatal heart disease. The physicians suggest that perhaps even patients who are still teenagers could get early warnings, and begin taking preventative measures.

Dan Anderson, MD, PhD, an assistant professor in the Division of Cardiology at the University of Nebraska Medical Center, said, “In the current realm of understanding disease, we know that inflammation is important in cardiovascular disease. But we really don't understand a lot about why or how. We should have seen and recognized this decades prior, and prevented it. People tend to feel okay and think they're okay. But they're not even seeing the tip of the iceberg." According to the team, about 30% of people who have heart disease somehow slip through the cracks, in what Prof. Anderson terms “a failure of medicine.”

Related Links:
University of Nebraska
UNeMed Corporation


Gold Member
Blood Gas Analyzer
GEM Premier 7000 with iQM3
Automated Blood Typing System
IH-500 NEXT
New
Lab Sample Rotator
H5600 Revolver
New
Silver Member
Apolipoprotein A-I Assay
Apo A-I Assay

Print article

Channels

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.